Chemomab Therapeutics (CMMB) Short Interest Ratio & Short Volume

$0.67
+0.01 (+1.52%)
(As of 04/23/2024 ET)

Chemomab Therapeutics Short Interest Data

Current Short Volume
221,900 shares
Previous Short Volume
194,200 shares
Change Vs. Previous Month
+14.26%
Dollar Volume Sold Short
$172,860.10
Short Interest Ratio / Days to Cover
1.0
Last Record Date
March 31, 2024
Outstanding Shares
11,050,000 shares
Float Size
11,870,000 shares
Short Percent of Float
1.87%
Today's Trading Volume
7,157 shares
Average Trading Volume
195,383 shares
Today's Volume Vs. Average
4%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Chemomab Therapeutics ?

Sign up to receive the latest short interest report for Chemomab Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CMMB Short Interest Over Time

CMMB Days to Cover Over Time

CMMB Percentage of Float Shorted Over Time

Chemomab Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024221,900 shares $172,860.10 +14.3%1.9%1 $0.78
3/15/2024194,200 shares $155,224.06 -20.5%1.8%0.8 $0.80
2/29/2024244,300 shares $167,345.50 +549.7%2.5%0.9 $0.69
2/15/202437,600 shares $22,936.00 +15.7%0.4%0.1 $0.61
1/31/202432,500 shares $18,752.50 +5.5%0.3%0 $0.58
1/15/202430,800 shares $17,217.20 -23.8%0.3%0 $0.56
12/31/202340,400 shares $20,604.00 +125.7%0.3%0 $0.51
12/15/202317,900 shares $9,039.50 -84.8%0.1%0 $0.51
11/30/2023117,900 shares $63,548.10 +287.8%1.2%0.1 $0.54
11/15/202330,400 shares $24,836.80 -5.6%0.3%0 $0.82
10/31/202332,200 shares $23,583.28 -28.1%0.3%1.7 $0.73
10/15/202344,800 shares $39,827.20 -2.6%0.5%2.4 $0.89
9/30/202346,000 shares $41,170.00 +23.0%0.5%2 $0.90
9/15/202337,400 shares $40,766.00 -9.2%0.4%0.7 $1.09
8/31/202341,200 shares $45,732.00 -8.9%0.4%0.2 $1.11
8/15/202345,200 shares $50,624.00 -19.6%0.5%0.3 $1.12
7/31/202356,200 shares $71,936.00 -43.4%0.5%0.3 $1.28
7/15/202399,200 shares $139,872.00 +6.6%0.9%0.6 $1.41
6/30/202393,100 shares $121,961.00 -69.1%1.1%0.5 $1.31
6/15/2023301,700 shares $512,890.00 -7.6%3.4%1.8 $1.70
5/31/2023326,500 shares $512,605.00 -22.8%3.7%11.9 $1.57
5/15/2023422,900 shares $689,327.00 -7.3%4.8%5.7 $1.63
4/30/2023456,300 shares $679,887.00 -11.8%4.9%1 $1.49
4/15/2023517,400 shares $838,188.00 +1.5%5.6%1.1 $1.62
3/31/2023510,000 shares $810,900.00 -15.7%5.5%1.1 $1.59
3/15/2023605,200 shares $913,852.00 -8.2%7.1%0.7 $1.51
2/28/2023658,900 shares $1.02 million +457.9%7.7%0.8 $1.55
2/15/2023118,100 shares $237,381.00 +3.9%1.4%0.1 $2.01
1/31/2023113,700 shares $261,510.00 -24.8%1.4%0.3 $2.30
1/15/2023151,200 shares $341,712.00 +269.7%1.8%0.3 $2.26
12/30/202240,900 shares $130,880.00 -19.7%0.5%0.1 $3.20
12/15/202250,900 shares $109,435.00 +155.8%0.6%1 $2.15
11/30/202219,900 shares $41,790.00 -69.9%0.3%0.5 $2.10
11/15/202266,100 shares $134,844.00 +66,000.0%0.8%1.6 $2.04
10/31/2022100 shares $204.00 No ChangeN/A0 $2.04
10/15/2022100 shares $200.00 -93.3%N/A0 $2.00
9/30/20221,500 shares $3,735.00 -83.0%0.0%0 $2.49
9/15/20228,800 shares $28,776.00 -36.7%0.1%0.2 $3.27
8/31/202213,900 shares $45,592.00 -42.3%0.2%0.3 $3.28
8/15/202224,100 shares $94,954.00 +230.1%0.3%0.5 $3.94
The only defense company you should be looking at (Ad)

This is the ONLY defense company you should be watching right now.

Get all the info here >>>

CMMB Short Interest - Frequently Asked Questions

What is Chemomab Therapeutics' current short interest?

Short interest is the volume of Chemomab Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 221,900 shares of CMMB short. 1.87% of Chemomab Therapeutics' shares are currently sold short. Learn More on Chemomab Therapeutics' current short interest.

What is a good short interest ratio for Chemomab Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMMB shares currently have a short interest ratio of 1.0. Learn More on Chemomab Therapeutics's short interest ratio.

What is a good short interest percentage for Chemomab Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.87% of Chemomab Therapeutics' floating shares are currently sold short.

Is Chemomab Therapeutics' short interest increasing or decreasing?

Chemomab Therapeutics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 221,900 shares, an increase of 14.3% from the previous total of 194,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Chemomab Therapeutics' float size?

Chemomab Therapeutics currently has issued a total of 11,050,000 shares. Some of Chemomab Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Chemomab Therapeutics currently has a public float of 11,870,000 shares.

How does Chemomab Therapeutics' short interest compare to its competitors?

1.87% of Chemomab Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Chemomab Therapeutics: eFFECTOR Therapeutics, Inc. (10.72%), Trevena, Inc. (0.63%), Tenax Therapeutics, Inc. (2.62%), Pasithea Therapeutics Corp. (1.17%), Pulmatrix, Inc. (0.07%), Sunshine Biopharma, Inc. (0.77%), Lixte Biotechnology Holdings, Inc. (0.97%), Clever Leaves Holdings Inc. (1.15%), Enveric Biosciences, Inc. (4.23%), Shuttle Pharmaceuticals Holdings, Inc. (0.72%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Chemomab Therapeutics stock?

Short selling CMMB is an investing strategy that aims to generate trading profit from Chemomab Therapeutics as its price is falling. CMMB shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Chemomab Therapeutics?

A short squeeze for Chemomab Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CMMB, which in turn drives the price of the stock up even further.

How often is Chemomab Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMMB, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CMMB) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners